NEOS Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
NEOS Investment Management's BIIB Position: Q2 2026 in Review
NEOS Investment Management increased its Biogen (BIIB) stake by 14% in Q2 2026, buying an estimated $554K and bringing the position to 23,734 shares worth $5.13M. The position accounts for 0.02% of the portfolio, ranked #359.
NEOS Investment Management first reported a position in BIIB in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.03M in Q3 2025. 1,044 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- NEOS Investment Management held 23,734 shares of Biogen worth $5.13M as of Q2 2026.
- NEOS Investment Management bought 2,894 Biogen shares in Q2 2026, an estimated $554K.
- Biogen made up 0.02% of NEOS Investment Management's portfolio in Q2 2026, its #359 holding.
- NEOS Investment Management first reported a position in Biogen in Q3 2023 and has held it in 12 quarters since.
- NEOS Investment Management's Biogen position peaked at $8.03M in Q3 2025.
- 1,044 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.